Amarin Corp Plc (AMRN)

[KCSVEN]

It's a 4% decrease compared to placebo which is considered not significant, if the other baselines were only 4% improvement the drug would never have passed, in other words it's such a small change that
1) The effects are negligible
2) A larger sample may show no change or slightly more or less that at 4% you can't say Vascepa lowers HDL but total cholesterol less good cholesterol of 18%